Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced today that Adrian L. Rabinowicz, M.D., FAAN, has joined the Company as Senior Vice President and Head, Medical Affairs, reporting to Thomas Wessel, M.D., Ph.D., Chief Medical Officer. Dr. Rabinowicz will have responsibility for Acorda’s Medical Communications and Scientific Affairs departments, medical education programs and the field-based team of Regional Scientific Managers.
MORE ON THIS TOPIC